Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,174 across all filing types
Latest filing 2024-11-19 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Intimation regarding issuance of duplicate share certificate.
Regulatory Filings Classification · 95% confidence The document is a compliance certificate issued under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the issuance of a duplicate share certificate in lieu of a lost share certificate. The document is a formal regulatory compliance submission to stock exchanges and does not contain financial statements, management discussion, or report data. It is not an announcement of a report but a regulatory filing related to share certificate compliance. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (2821 characters), and it is a certificate rather than a report or announcement of a report.
2024-11-19 English
Intimation regarding allotment of 2642 shares under ESOP.
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) disclosing the allotment of shares under the company's Employee Stock Option Plan (ESOP). It references Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content specifically details the allotment of fully paid-up equity shares upon exercising vested options by employees. There is no financial report, earnings data, or management discussion. The document is an announcement about a capital change (share allotment under ESOP). Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is short and it is not a report publication announcement or certification. Confidence is high due to clear mention of share allotment under ESOP and regulatory reference.
2024-11-19 English
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the allotment of shares under the company's Employee Stock Option Plan (ESOP). It specifies the number of shares allotted and the exercise of vested options by employees. The document references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30(2), which pertains to disclosure of material events. The content is an announcement of a capital change event (allotment of shares) rather than a full report or financial statement. The document length is short (1842 characters), and it is clearly an announcement of a share allotment under ESOP. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2024-11-19 English
Intimation regarding loss of share certificate by the shareholder.
Regulatory Filings Classification · 100% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificate details from a shareholder. It is a regulatory compliance filing related to share certificate loss, not a financial report, management change, or voting result. The document is short (2605 characters) and serves as a formal notification to stock exchanges. It does not contain financial data or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-11-14 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificate details received from a shareholder. It is addressed to stock exchanges and signed by the company secretary. The document does not contain financial statements, management discussion, or any report content. It is a regulatory compliance filing related to share certificate loss, which does not fit into financial reports or other specific categories. Given its nature and length (2605 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2024-11-14 English
Intimation about participating in the Analyst/Institutional Investors Meet.
Regulatory Filings Classification · 95% confidence The document is a disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing about the management's participation in an upcoming Analyst/Institutional Investors Meet. It mentions the date, organizer, location, and mode of the meeting. There is no financial data, report content, or detailed presentation included, only an announcement of the event. The document length is short (1874 characters), and it serves as a notification rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2024-11-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.